Trial Profile

Combination Gefitinib and Methotrexate to Medically Treat Ectopic Pregnancies: A Phase I Clinical Toxicity Trial.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Gefitinib (Primary) ; Methotrexate
Indications Ectopic pregnancy
Focus Adverse reactions; Therapeutic Use

Most Recent Events

09 Apr 2012 Actual initiation date (4 Nov 2010) added as reported by Australian New Zealand Clinical Trials Registry.
09 Apr 2012 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
20 Jul 2011 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com